Abstracts

INNATE IMMUNITY PREDICTORS OF HIV RISK LINKED TO GENITAL HERPES

Incident HSV-2 infection is associated with over threefold increase in risk of HIV acquisition. Understanding the underlying mechanisms is a research priority given the high global HSV-2 prevalence ranging from 39 to 83 % among women in Sub-Saharan Africa. We hypothesized that: 1) aberrant innate immunity predisposes to both HIV-1 and HSV-2, and 2) innate…

EFFECT OF ANTIMICROBIALS ON PENILE BACTERIAL DENSITY AND FORESKIN INFLAMMATION

The composition of the penile microbiome, particularly abundance of specific anaerobic taxa, has been associated with HIV acquisition, potentially through promoting foreskin production of cytokines that recruit HIV target cells to the foreskin. However, little is known regarding the impact of topical or oral medications on penile microbiome composition or foreskin immunology. We conducted a…

IN SITU FORMING IMPLANTS WITH CABOTEGRAVIR FOR ULTRA-LONG-ACTING PrEP

Bi-monthly Cabotegravir long-acting (CAB LA) is expected to soon be available as a new option for HIV prevention. Biodegradable in situ forming implants (ISFI) releasing CAB represent an attractive ultra-long-acting delivery platform that can provide sustained drug release for several months to years but can be removed to terminate treatment if needed. We evaluated drug…

PHASE I TRIAL OF SUBCUTANEOUSLY ADMINISTERED VRC07-523LS AND PGT121

Effective,long-acting HIV prevention approaches are needed,especially for young women in Africa.We evaluated the safety and pharmacokinetics of monoclonal antibodies VRC07-523LS and PGT121 administered subcutaneously alone and in combination,as passive immunisation to young women in South Africa CAPRISA 012A was a randomised,double-blinded,placebo-controlled,dose-escalation trial.Safety,tolerability,pharmacokinetics,serum neutralization activity and antidrug-antibody levels were assessed.45 HIV-negative participants aged 18-40 years were…

TAF/EVG DUAL-COMPARTMENT INSERT EFFICACY AGAINST RECTAL SHIV TRANSMISSION IN MACAQUES

Topical on-demand HIV prevention modalities are a desirable alternative to daily oral or long-acting injectable PrEP. CONRAD has developed inserts containing tenofovir alafenamide (TAF) and elvitegravir (EVG) for on-demand vaginal or rectal pericoital use, which are currently in early clinical testing. TAF/EVG inserts provided high protection as PrEP or PEP in pigtailed macaques exposed vaginally…

STOPCoV: SAFETY AND EFFICACY OF PREVENTATIVE COVID VACCINES

In attempts to rapidly immunize a greater proportion of the Ontario population against COVID, public health officials recommended extending the interval between vaccine doses and allowed ‘mixing of vaccine types’. The impact of these decisions on the antibody response to the vaccine, particularly in the community dwelling elderly population is unknown. The STOPCoV study is…